Overview

Efficacy and Safety of a Collagen Bupivacaine Implant in Women Following Abdominal Hysterectomy

Status:
Completed
Trial end date:
2008-09-05
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the CollaRx Bupivacaine implant is safe and effective in reducing the amount of narcotic pain medication needed to control pain during the first 24 hours after abdominal hysterectomy surgery.
Phase:
Phase 2
Details
Lead Sponsor:
Innocoll
Collaborator:
Premier Research Group plc
Treatments:
Bupivacaine